Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

Journal:

Nature Medicine

Published:

2026-01-27

DOI:

10.1038/s41591-025-04177-6

Affiliations:

6

Authors:

62

Go to article

Institutions	Authors	Share
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	56.000000 56.000000 56.000000 56.000000 56.000000 56.000000	0.90
Regeneron Pharmaceuticals, United States of America (USA)	4.000000	0.06
National Cancer Center (NCC), Japan	2.000000	0.03

Interested in Oncology and Carcinogenesis?